Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Drug Treatment of Sleep Disorders, Hardback Book

Drug Treatment of Sleep Disorders Hardback

Edited by Antonio Guglietta

Part of the Milestones in Drug Therapy series

Hardback

Description

Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders.

These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g.

Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.

Information

Save 13%

£119.99

£104.05

Item not Available
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Milestones in Drug Therapy series  |  View all